The overexpression of the oncogene MYBL2 (also known as B-Myb, MYB roto-oncogene like 2) has been confirmed to be associated with an increased rate of cell proliferation and can also become a valuable biomarker for poor cancer prognosis. Here, MYBL2 is linked to cancer.